Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients
1989585 citationsMaurice Stroun, Philippe Anker et al.Oncologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Mirko Beljanski
Since
Specialization
Citations
This map shows the geographic impact of Mirko Beljanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirko Beljanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirko Beljanski more than expected).
This network shows the impact of papers produced by Mirko Beljanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirko Beljanski. The network helps show where Mirko Beljanski may publish in the future.
Co-authorship network of co-authors of Mirko Beljanski
This figure shows the co-authorship network connecting the top 25 collaborators of Mirko Beljanski.
A scholar is included among the top collaborators of Mirko Beljanski based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Mirko Beljanski. Mirko Beljanski is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Beljanski, Mirko. (2013). The Regulation of DNA Replication and Transcription.2 indexed citations
Beljanski, Mirko & Sylvain Crochet. (1994). Differential effects of ferritin, calcium, zinc, and gallic acid on in vitro proliferation of human glioblastoma cells and normal astrocytes.. PubMed. 123(4). 547–55.10 indexed citations
5.
Stroun, Maurice, Philippe Anker, P Maurice, et al.. (1989). Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients. Oncology. 46(5). 318–322.585 indexed citations breakdown →
Beljanski, Mirko. (1983). The Regulation of DNA Replication and Transcription: The Role of Trigger Molecules in Normal and Malignant Gene Expression. Medical Entomology and Zoology.1 indexed citations
Beljanski, Mirko, et al.. (1975). [RNA fragments, in vivo inhibitors of Shope fibroma and vaccinia virus multiplication].. PubMed. 280(6). 783–9.1 indexed citations
Beljanski, Mirko. (1973). [Separation of reverse transcriptase from DNA-dependant DNA polymerase. Analysis of DNA synthetized on the model of RNA transformans].. PubMed. 276(10). 1625–8.1 indexed citations
14.
Beljanski, Mirko & P Bourgarel. (1971). [RNA episome carried by the DNA of wild and showdomycin-resistant Escherichia coli].. PubMed. 272(21). 2736–9.2 indexed citations
Beljanski, Mirko & P Bourgarel. (1971). [Transforming RNA bearers of hereditary characters in showdomycino-resistant Escherichia coli].. PubMed. 272(16). 2107–10.3 indexed citations
17.
Beljanski, Mirko, et al.. (1970). [Showdomycin and biosynthesis of RNA non complementary to DNA. I].. PubMed. 118(3). 253–76.4 indexed citations
18.
Beljanski, Mirko, et al.. (1968). [Synthesis in Escherichia coli of RNA whose primary structure differs entirely from that of DNA].. PubMed. 267(12). 1058–60.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.